Market Overview:
The global buprenorphine hydrochloride tablets market is expected to register a CAGR of xx% during the forecast period 2018-2030. The market growth can be attributed to factors such as, increasing prevalence of chronic pain, rising demand for opioid antagonists and growing awareness about the benefits of buprenorphine hydrochloride tablets. However, the high cost associated with the treatment is likely to restrain the growth of this market during the forecast period. Based on type, the global buprenorphine hydrochloride tablets market has been segmented into 0.5mg and 2mg. The 2mg segment is expected to account for a larger share in terms of revenue in 2018 and is projected to register a CAGR of xx% duringthe forecast period. This can be attributedto its higher efficacy as an analgesic agent as compared to 0.5 mg dosage form .
Product Definition:
Buprenorphine hydrochloride tablets are a narcotic analgesic used to relieve pain. It is also used to treat moderate to severe chronic pain when other treatments and medicines have not worked well enough.
0.5mg:
0.5mg is a generic name for buprenorphine, which is a semi-synthetic opioid analgesic and an active ingredient of the opiate drug class. It's an analog of thebaine that was developed as an alternative to morphine, it has about 5-6 times more potent than Morphine in terms of its effect on the human body and can be administered relatively quickly compared to Morphine itself.
2mg:
2mg Buprenorphine Hydrochloride Tablets are used to relieve pain and as a part of the treatment for chronic pain. It is also used to reduce the effects of opiate addiction. 2mg buprenorphine hydrochloride tablets contain the same amount of active ingredient as 8mg tablet, but due to their smaller size they offer less dose compared to larger sized tablets.
Application Insights:
The analgesic segment dominated the global buprenorphine hydrochloride tablets market in 2017, accounting for over 60.0% share of the total revenue. This is attributed to rising usage of these tablets for pain management as an alternative to strong opioids, such as morphine. Moreover, increasing incidences of chronic pain are expected to boost demand for these tablets over the forecast period.
Buprenorphine is widely used for opioid dependence and treatment-resistant depression due largely on its high efficacy and low potential for abuse compared to other opioid drugs like heroin and morphine. However, there are limited data on use of this drug in anxiety disorders; hence it is being studied extensively by researchers worldwide regarding its utility in treating anxiety disorders including social phobia and panic disorder with relatively fewer side effects when compared with other anti-anxiety medication options available globally such as benzodiazepines and SSRIs ( selective serotonin reuptake inhibitors).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of players and high consumption. The region is expected to maintain its dominance over the forecast period due to increasing cases of chronic pain, opioid addiction, rising awareness about alternative treatment options for opioid dependence and growing preference for OTC products.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure, economic development in emerging countries and rising disposable income among patients. These factors are anticipated to contribute toward growth during the forecast years from 2018 through 2030 timeframe. Moreover, government initiatives regarding buprenorphine hydrochloride tablets distribution will also boost revenue generation in this region during the same period. For instance; In India; Sun Pharmaceutical Industries Ltd., WOCKHARDT GMBH & CO., KALVIS LTD., Dr.-Kerr-Pharmaceuticals GmbH & Co., Cipla Inc.
Growth Factors:
- Increasing awareness about the benefits of buprenorphine hydrochloride tablets among healthcare professionals and patients
- Rising demand for effective pain management therapies
- Growing number of product approvals and launches by key players
- Increasing adoption of buprenorphine hydrochloride tablets in emerging markets
- Technological advancements in the manufacturing process
Scope Of The Report
Report Attributes
Report Details
Report Title
Buprenorphine Hydrochloride Tablets Market Research Report
By Type
0.5mg, 2mg
By Application
Analgesic, Opioid Antagonist
By Companies
Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Siegfried, Faranshimi, Teva
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
121
Number of Tables & Figures
85
Customization Available
Yes, the report can be customized as per your need.
Global Buprenorphine Hydrochloride Tablets Market Report Segments:
The global Buprenorphine Hydrochloride Tablets market is segmented on the basis of:
Types
0.5mg, 2mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Analgesic, Opioid Antagonist
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siegfried
- Sanofi
- Johnson Matthey
- Mallinckrodt
- Noramco
- Unichemlabs
- Arevipharma
- Resonance-labs
- Sun Pharma
- Rusan Pharma
- Siegfried
- Faranshimi
- Teva
Highlights of The Buprenorphine Hydrochloride Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0.5mg
- 2mg
- By Application:
- Analgesic
- Opioid Antagonist
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Buprenorphine Hydrochloride Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Buprenorphine hydrochloride tablets are a medication used to treat opioid addiction. They work by helping people feel less pain and reducing their cravings for opioids. Buprenorphine hydrochloride tablets are usually taken as an outpatient treatment, with regular check-ups.
Some of the key players operating in the buprenorphine hydrochloride tablets market are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Siegfried, Faranshimi, Teva.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Buprenorphine Hydrochloride Tablets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Buprenorphine Hydrochloride Tablets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Buprenorphine Hydrochloride Tablets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Buprenorphine Hydrochloride Tablets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Buprenorphine Hydrochloride Tablets Market Size & Forecast, 2018-2028
4.5.1 Buprenorphine Hydrochloride Tablets Market Size and Y-o-Y Growth
4.5.2 Buprenorphine Hydrochloride Tablets Market Absolute $ Opportunity
Chapter 5 Global Buprenorphine Hydrochloride Tablets Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Buprenorphine Hydrochloride Tablets Market Size Forecast by Type
5.2.1 0.5mg
5.2.2 2mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Buprenorphine Hydrochloride Tablets Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Buprenorphine Hydrochloride Tablets Market Size Forecast by Applications
6.2.1 Analgesic
6.2.2 Opioid Antagonist
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Buprenorphine Hydrochloride Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Buprenorphine Hydrochloride Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Buprenorphine Hydrochloride Tablets Analysis and Forecast
9.1 Introduction
9.2 North America Buprenorphine Hydrochloride Tablets Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Buprenorphine Hydrochloride Tablets Market Size Forecast by Type
9.6.1 0.5mg
9.6.2 2mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Buprenorphine Hydrochloride Tablets Market Size Forecast by Applications
9.10.1 Analgesic
9.10.2 Opioid Antagonist
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Buprenorphine Hydrochloride Tablets Analysis and Forecast
10.1 Introduction
10.2 Europe Buprenorphine Hydrochloride Tablets Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Buprenorphine Hydrochloride Tablets Market Size Forecast by Type
10.6.1 0.5mg
10.6.2 2mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Buprenorphine Hydrochloride Tablets Market Size Forecast by Applications
10.10.1 Analgesic
10.10.2 Opioid Antagonist
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Buprenorphine Hydrochloride Tablets Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Buprenorphine Hydrochloride Tablets Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Buprenorphine Hydrochloride Tablets Market Size Forecast by Type
11.6.1 0.5mg
11.6.2 2mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Buprenorphine Hydrochloride Tablets Market Size Forecast by Applications
11.10.1 Analgesic
11.10.2 Opioid Antagonist
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Buprenorphine Hydrochloride Tablets Analysis and Forecast
12.1 Introduction
12.2 Latin America Buprenorphine Hydrochloride Tablets Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Buprenorphine Hydrochloride Tablets Market Size Forecast by Type
12.6.1 0.5mg
12.6.2 2mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Buprenorphine Hydrochloride Tablets Market Size Forecast by Applications
12.10.1 Analgesic
12.10.2 Opioid Antagonist
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Buprenorphine Hydrochloride Tablets Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Buprenorphine Hydrochloride Tablets Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Buprenorphine Hydrochloride Tablets Market Size Forecast by Type
13.6.1 0.5mg
13.6.2 2mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Buprenorphine Hydrochloride Tablets Market Size Forecast by Applications
13.10.1 Analgesic
13.10.2 Opioid Antagonist
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Buprenorphine Hydrochloride Tablets Market: Competitive Dashboard
14.2 Global Buprenorphine Hydrochloride Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siegfried
14.3.2 Sanofi
14.3.3 Johnson Matthey
14.3.4 Mallinckrodt
14.3.5 Noramco
14.3.6 Unichemlabs
14.3.7 Arevipharma
14.3.8 Resonance-labs
14.3.9 Sun Pharma
14.3.10 Rusan Pharma
14.3.11 Siegfried
14.3.12 Faranshimi
14.3.13 Teva
